[1] MRC working party. (1992). Medical research council trial of treatment of hypertension in older adults. Principal results BMJ, Vol. 304, no. 6824, pp.405-412.
[2] Wander G.S., Chhabra S.T. and Kaur K. (2009). Atenolol drug profile. JAPI Supplement: Journal of Association of Physicians of India, Vol. 57, pp. 13-16.
[3] Lund Johansen, P. (1976). Hemodynamic long-term effects of a new b-adrenoceptor blocking drug, Atenolol (ICI66082), in essential hypertension. Br J Clin Pharmacol, Vol. 3, no. 3, pp. 445-451.
[4] Mikhailidis D. P., Khan M.A., Milionis H. J. and Morgan R. J. (2001) The Treatment of Hypertension in Patients with Erectile Dysfunction. Current Medical Research and Opinion, Vol.16, pp.31-36.
[5] Brown H.C., Carruthers S. G. and Johnson G. D.et al (1976): Clinical pharmacologic observations on atenolol, a beta adrenoceptor blocker. Clin pharmacol Ther., Vol.20, no .5, pp. 34-524.
[6] Sullivan J. M. (1996). Atenolol; Cardiovascular Drug therapy. 2nd edition, pp 48-540.
[7] Astrom H .and Vallin H. (1977) Effect of atenolol on exercise haemodynamics in angina pectoris and hyper tension. Post grad Med J., Vol. 53, pp.3- 84.
[8] Duprez D.A., Florea N., Duval S. and Cohn J. N. (2018). Effect of nebivolol or atenolol vs. placebo on cardiovascular health in subjects with borderline blood pressure: the Evidence study. J Hum Hypertens ,Vol.32, pp. 20–25.
[9] Thomas T. and Dooley T. P .(2018). Treatment of Anxiety Prior to a Medical Procedure using an Atenolol - Scopolamine Combination Drug, J Depress Anxiety, Vol. 7, pp. 1-5.
[10] Lindholm L. H., Carlberg B. and Samuelsson O. (2005). Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet (London, England), Vol. 366, no. 9496, pp. 1545–1553.
[11] Vincent H. H., Boomsma F., Man in't Veld A. J., Derkx F. H., Wenting G. J. and Schalekamp M. A. (1984). Effects of selective and nonselective beta-agonists on plasma potassium and norepinephrine. Journal of cardiovascular pharmacology, Vol. 6, no. 1, pp. 107–114.
[12] Ra J., Yoom H., Son H., Hwang T. and Lee Y. (2019). Transformation of an Amine Moiety of Atenolol during Water Treatment with Chlorine/UV: Reaction Kinetics, Products, and Mechanisms, Environ. Sci. Technol., Vol. 53, pp.7653−7662.
[13] Remucal C. K. and Manley D. (2016). Emerging investigators series: the efficacy of chlorine photolysis as an advanced oxidation process for drinking water treatment. Environmental Science: Water Research &Technology, Vol. 2, no. 4, pp. 565−579.
[14] Watts M. J. and Linden K. G. (2007). Chlorine photolysis and subsequent OH radical production during UV treatment of chlorinated water. Water research, Vol. 41, no. 13, pp. 2871–2878.
[15] Sedaghat S. (2014). Synthesis and Modification of Carboxylated Multi Wall Nanotubes with Atenolol. Soft Nanoscience Letters, Vol. 4, no.3, pp. 75-81.
[16] Tahermansouri H., Chobforosh , D. and Meskinfam, M. (2010). Functionalization of Carboxylated Multi-Wall Nanotubes with 1,2-phenylenediamine. International Journal of Nano Dimension, Vol. 1, pp. 153-159.
[17] Kalita G., Adhikari S., Aryal H. R., Afre R., Soga T., Sharon M. and Umeno M. (2009). Functionalization of Multi-Walled Carbon Nanotubes (MWCNTs) with Nitrogen Plasma for Photovoltaic Device Application. Current Applied Physics, Vol.9, no. 2, pp. 346-351.
)
